Biofrontera Inc. Operating Lease, Weighted Average Discount Rate, Percent
Biofrontera Inc. (BFRI) had Operating Lease, Weighted Average Discount Rate, Percent of 9.90% as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-08-13
- 2026-06-30: Operating Lease, Weighted Average Discount Rate, Percent 9.90%.
- 2026-03-31: Operating Lease, Weighted Average Discount Rate, Percent 9.90%.
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 9.88%.
- 2024-12-31: Operating Lease, Weighted Average Discount Rate, Percent 8.22%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2026-06-30 | 9.90% 10-Q · filed 2026-08-13 |
| 2026-03-31 | 9.90% 10-Q · filed 2026-05-14 |
| 2025-12-31 | 9.88% 10-K · filed 2026-03-19 |
| 2024-12-31 | 8.22% 10-K · filed 2026-03-19 |
| 2023-12-31 | 7.76% 10-K · filed 2025-03-20 |
| 2023-09-30 | 6.75% 10-Q · filed 2023-11-09 |
| 2023-06-30 | 6.31% 10-Q · filed 2023-08-11 |
| 2023-03-31 | 6.31% 10-Q · filed 2023-05-12 |
| 2022-12-31 | 6.31% 10-K · filed 2024-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |